Neoadjuvant immunotherapy improves outlook in high-risk melanoma

ESMO 2022: Highlights, commentary and analysis

A new era of early cancer detection with blood test may change cancer screening paradigms

New era of early cancer detection blood tests on the horizon

Prognostic model of all-cause mortality at 30 days in patients with cancer and COVID-19

New data presented at ESMO for multi-cancer early detection

Treatment with tumour-infiltrating lymphocytes versus ipilimumab significantly improved PFS for advanced melanoma

Tumour-infiltrating lymphocyte treatment for advanced melanoma

Working to improve global cancer care access in low middle-income countries

Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes

War in Ukraine: Global cancer aid to support refugees

ASCO and WHO to collaborate on quality indicators for cancer facilities